Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

PP405 may help hair growth by activating hair follicle stem cells.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.

A new compound may treat benign prostatic hyperplasia better than finasteride.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Eflornithine cream slows facial hair growth and works well with other treatments.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Combining eflornithine cream with laser treatment removes facial hair better than laser alone.

Euphorbia hirta oil may promote hair growth naturally.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

EISA uses enzymes to create precise nanostructures in cells, offering new ways to design adaptive materials and therapies.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.